Caption Management, LLC Rocket Pharmaceuticals, Inc. Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$17.6 - $25.88 $704,000 - $1.04 Million	40,000 Added 66.67%	100,000 $1.85 Million
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $619,800 - $801,600	30,000 Added 100.0%	60,000 $1.29 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $416,144 - $792,112	24,800 Added 476.92%	30,000 $899,000
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $78,364 - $125,060	5,200 New	5,200 $106,000
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $1.93 Million - $2.84 Million	124,600 Added 54.51%	353,200 $6.91 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $2.83 Million - $4.21 Million	228,600 New	228,600 $3.65 Million
Q3 2021 Nov 12, 2021	SELL	$27.42 - $48.97 $830,826 - $1.48 Million	-30,300 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $1.19 Million - $1.43 Million	30,300 New	30,300 $1.34 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $875M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.